Brain Atrophy and Cerebral Small Vessel Disease

activity, which is better than clinical scores.7 Brain atrophy has been used as an outcome measure in treatment trials.8,9 In comparison to multiple sclerosis, there are less data on brain atrophy in SVD with white matter hyperintensity lesion volume being the most widely reported. The progression of ................
................